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IntroductIon
The development of metabolic syndrome and type 2 diabetes is 
linked to obesity-induced inflammation in visceral adipose  tissue 
(1). Adipose tissue contains a wide variety of leukocytes (e.g., 
monocytes, macrophages, mast cells, B and T lymphocytes, and 
neutrophils), but adipose tissue macrophages (ATMs) are thought 
to be the major effectors of adipose tissue inflammation (2). In 
lean mice and humans, visceral fat contains predominantly resi-
dent (type 2) ATMs that express markers of  alternative (M2) mac-
rophage activation (3–5). However, obesogenic diets (Western or 
high fat) promote quantitative and qualitative changes in ATM 
subtypes within fat that are associated with measures of inflam-
mation and insulin resistance (5–7). Specifically, high-fat diets 
(HFD) promote the recruitment of inflammatory (type 1) ATMs 
that express the marker CD11c, produce pro- inflammatory 
cytokines, and cluster around dead adipocytes (8,9). Ablation of 
CD11c+ ATMs in obese mice reduces inflammation and improves 
insulin sensitivity, establishing a link between the infiltration of 
type 1 ATMs and metabolic disease (10). However, the mecha-
nisms by which monocytes/ATMs traffic to adipose tissue during 
steady state and in response to obesity are incompletely under-
stood and a key question in the field.
The accumulation of inflammatory type 1 ATMs in obese vis-
ceral fat mimics foam cell accumulation in atherosclerotic vessels 
(11,12). Moreover, both foam cell formation and recruitment of 
type 1 ATMs to fat are dependent upon the chemokine receptor 
CCR2 and its ligand CCL2/MCP1 (13–16). Recent studies have 
also demonstrated that other inflammatory mediators com-
monly found in atherosclerotic plaques (e.g., T cells, B cells, and 
mast cells) are enriched in obese adipose tissue as well (17–19). 
Collectively, these findings have led to the generally held idea 
that factors which regulate foam cell formation during athero-
genesis may be synonymous with those that promote ATM 
accumulation and adipose tissue inflammation with obesity.
In addition to CCR2, the fractalkine receptor CX3CR1 regu-
lates monocyte trafficking to sites of inflammation and plays 
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a critical role in foam cell formation. CX3CR1 is differentially 
expressed on two distinct subsets of blood monocytes. In mice, 
resident monocytes (CD115+ Ly-6c− (Gr-1−) 7/4Mid CX3CR1
High 
CCR2−) are long-lived, patrolling leukocytes that give rise to 
tissue macrophages under homeostatic conditions; conversely, 
inflammatory monocytes (CD115+ Ly-6cHigh (Gr-1+) 7/4High 
CX3CR1
Mid CCR2High CD62L+) are short-lived and migrate 
rapidly from the circulation into inflamed tissues (20,21). 
CX3CR1 enhances Ly-6c
High monocyte adhesion to endothelial 
cells (22), but also promotes the survival of circulating Ly-6cLow 
monocytes (23). Disruption of either CX3CR1 or it ligand 
(fractalkine/CX3CL1) attenuates macrophage accumulation 
and inflammation in mice models of atherosclerosis (24–26). 
Notably, CX3CR1/CX3CL1 synergizes with CCR2/CCL2 to 
maximize foam cell formation and the inflammatory response 
during atherogenesis (14,27,28). Whether CX3CR1/CX3CL1 
plays a similar role in ATM accumulation is unknown.
Recently, fractalkine/CX3CL1 has been shown to be elevated 
in plasma and adipose tissue from obese patients (29), suggest-
ing that CX3CL1/CX3CR1 may also be involved in adipose tis-
sue inflammation. Based on this finding and the importance 
of CX3CR1 and CX3CL1 in monocyte trafficking and foam cell 
formation, we examined the hypothesis that CX3CR1 regulates 
ATM recruitment during HFD-induced obesity. Unlike athero-
sclerosis models, our data indicate that CX3CR1 is not required 
for trafficking of resident type 2 ATMs or for obesity-induced 
accumulation of inflammatory type 1 ATMs. Ultimately, we 
found that Cx3cr1 deficiency does not impact HFD-induced 
insulin resistance or liver steatosis in mice. These findings 
suggest that monocytes/macrophages employ fundamentally 
different mechanisms to accumulate in adipose tissue during 
obesity as compared to atherosclerotic vessels.
Methods and Procedures
Mice and diets
C57BL/6J mice and B6.129P-Cx3cr1
tm1Litt/J (Cx3cr1
GFP/GFP) mice (C57BL/6 
background) were purchased from The Jackson Laboratory, Bar Harbor, 
ME. In Cx3cr1
GFP/GFP mice, both endogenous Cx3cr1 alleles are disrupted 
by an enhanced green fluorescent protein (GFP) reporter gene. Male 
Cx3cr1
GFP/GFP mice were crossed with female C57BL/6 mice to gener-
ate Cx3cr1
+/GFP hemizygous mice. Subsequently, male Cx3cr1
GFP/GFP mice 
were crossed with female Cx3cr1
+/GFP mice to generate Cx3cr1
+/GFP and 
Cx3cr1
GFP/GFP littermates. Beginning at 8–9 weeks of age, Cx3cr1
+/GFP and 
Cx3cr1
GFP/GFP male mice were fed a HFD consisting of 60% calories from 
fat (Research Diets, New Brunswick, NJ) to induce obesity. Lean con-
trol mice were fed normal diets (ND) consisting of 4.5% calories from 
fat (LabDiet 5002; PMI Nutrition International, St Louis, MO). Mice 
were housed in a specific pathogen-free facility on a 12-h light/12-h 
dark cycle and given free access to food and water. All animal use was 
in compliance with the Institute of Laboratory Animal Research Guide 
for the Care and Use of Laboratory Animals. Animal procedures were 
approved by the University Committee on Use and Care of Animals 
(UCUCA) at the University of Michigan.
rna extraction and real-time reverse transcription-Pcr 
analysis
Tissues were isolated, frozen in liquid nitrogen, and stored at −80 °C. 
Total RNA was isolated from adipose tissue, isolated adipocytes, 
and stromal vascular cells (SVCs) using the RNeasy Lipid Tissue 
Kit (Qiagen, Valencia, CA). In all cases, a DNase digestion step was 
 performed according to the manufacturer’s instructions. cDNA was 
generated from 0.5–1.0 mg total RNA using High Capacity cDNA 
Reverse Transcription Kits (Applied Biosystems, Carlsbad, CA). 
Real-time PCR analysis was performed using Power SYBR Green 
PCR Master Mix (Applied Biosystems) and the StepOnePlus System 
(Applied Biosystems). Arbp expression was used as the internal control 
for data normalization. DNA sequences for the PCR primers used for 
real-time PCR are provided (Supplementary Table S1 online). Samples 
were assayed in duplicate and relative expression was determined using 
the 2 −ΔΔCT method.
3t3L1 cell culture
3T3-L1 fibroblasts were propagated and differentiated into adipocytes 
as previously described (8). After differentiation (day 6), adipocytes 
were cultured at 37 °C and 8% CO2 in Dulbecco’s modified Eagle’s 
medium containing either 5 mmol/l or 25 mmol/l glucose and 10% 
fetal bovine serum and media was replaced daily. Adipocytes were used 
10 days after differentiation.
Bone marrow-derived macrophage culture
Bone marrow cells were harvested from C57BL/6 male mice and plated 
onto 12-well culture dishes at 1 × 106 cells/ml. Cells were grown in 
Dulbecco’s modified Eagle’s medium supplemented with 20% L929 
conditioned medium and 10% heat-inactivated fetal bovine serum for 
7 days before use.
Microscopy
Immunofluorescence microscopy was performed as previously 
described (8). Mice were perfused with 1% paraformaldehyde before 
tissues were dissected. Adipose tissue samples were incubated en bloc 
in primary and secondary antibodies in phosphate buffered saline 
(PBS) containing 5% bovine serum albumin (BSA). For intracellu-
lar staining with anti-GFP or anti-Caveolin antibodies, samples were 
stained in PBS/5% BSA containing 0.3% Triton X-100 (PBS-T/BSA). 
Adipose tissue and liver samples were fixed in 10% formalin overnight 
for histology. Paraffin sections were prepared and stained with hema-
toxylin and eosin. An Olympus DP72 camera attached to an Olympus 
inverted microscope was used to capture epifluorescence and hema-
toxylin and eosin images. Confocal images were captured with an 
Olympus FluoView microscope (60× water immersion objective) and 
processed with FluoView software (Olympus, Tokyo, Japan). Confocal 
images were pseudocolored in FluoView or Image J (National Institutes 
of Health, Bethesda, MD). Image J software was used to generate com-
posite images.
antibodies
Fc-block (anti-CD16/CD32) and anti-F4/80, anti-Mac2, anti-CD115-
PE, F4/80-PerCP5.5, Ly-6c-PerCP5.5, CD11c-PE-Cy7, Ly-6g-APC-Cy7, 
and CD11b-APC-Cy7 antibodies were from eBioscience, San Diego, 
CA. The CD206-APC antibody was from AbD Serotec, Raleigh, NC. The 
anti-GFP antibody was from AbCam, Cambridge, MA.  Anti-Caveolin 
antibody was from BD Biosciences, San Jose, CA. Isolectin-Alexa Fluor 
647 and Alexa Fluor-488, -568, and -647 conjugated secondary anti-
bodies were from Invitrogen, Carlsbad, CA.
Isolation of blood leukocytes
Mice were restrained and blood (50 ml) was collected from the tail vein 
in heparinized micro-hematocrit capillary tubes (Fisher, Pittsburgh, 
PA). Red blood cells were lysed in 1 ml H2O and blood leukocytes were 
resuspended in PBS/0.5% BSA before staining.
Isolation of adipose tissue sVcs
Mice were perfused with 10 ml PBS before fat pads were excised and 
minced in Hanks’ Balanced Salt Solution (HBSS; Invitrogen) con-
taining calcium, magnesium and 0.5% BSA. Collagenase (Type II; 
 Sigma-Aldrich, St Louis, MO) was added to a final concentration of 
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1 mg/ml and tissue suspensions were incubated at 37 °C for 20–30 min 
with constant shaking. The resulting cell suspensions were filtered 
through a 100-μm filter and centrifuged at 500 g for 10 min to separate 
floating adipocytes from the SVC-containing pellet. For some experi-
ment, SVCs were plated on cell culture dishes at 1 × 106 cells per ml. 
After 2–3 h, SVCs were rinsed with PBS and fresh Dulbecco’s modified 
Eagle’s medium containing 10% heat-inactivated fetal bovine serum 
was added. Cultured SVCs were used within 48 h of isolation. For RNA 
isolation, SVCs and isolated adipocytes were homogenized in QIAzol 
Lysis Reagent (Qiagen). For flow cytometry, SVCs were incubated in 
0.5 ml RBC lysis buffer for 5 min at room temperature and then resus-
pended in PBS/0.5% BSA.
Flow cytometry
Blood leukocytes and SVCs (107/ml) were incubated in Fc Block (rat 
anti-mouse CD16/CD32; eBioscience) for 15 min on ice. Cells were 
stained with the indicated antibodies for 30 min at 4 °C in the dark. 
Stained cells were washed twice in PBS and fixed in 0.1% paraformal-
dehyde. Cells were analyzed using a FACSCanto II Flow Cytometer (BD 
Biosciences) and WEASEL flow cytometry software (version 3.0.1 for 
Mac OSX; The Walter and Eliza Hall Institute).
Identification of crown-like structures
Adipose tissue samples were stained with anti-Caveolin and anti-Mac2 
antibodies in PBS-T/BSA. Samples were imaged using a 20× objective 
lens.
Glucose and insulin tolerance tests
Mice were fasted for 6 h (10:00 am–4:00 pm) before glucose tolerance 
tests and insulin tolerance tests. For glucose tolerance tests, D-glucose 
(0.7 g/kg of body weight) was administered by intraperitoneal injection. 
For insulin tolerance tests, human insulin (1 unit Humulin R (Eli Lilly, 
Indianapolis, IN) per kg of body weight) was delivered intraperito-
neally. Blood glucose concentrations (mg/dl) were measured 0, 15, 30, 
45, 60, 90, and 120 min after injection using a glucometer (One Touch 
Ultra; Lifescan, Milpitas, CA).
serum analysis
Blood samples were collected from the tail vein of restrained mice in 
serum-separating tubes (BD). Serum samples were frozen at −80 °C 
until analysis. Plasma insulin levels were measured using a mouse 
 insulin ELISA kit (Crystal Chem, Downers Grove, IL).
hepatic triglyceride content
Livers were weighed, snap frozen in liquid nitrogen, and stored at 
−80 °C. Frozen liver samples (200 mg) were thawed, homogenized in 
buffer A (50 mmol/l Tris, 5 mmol/l EDTA, 30 mmol/l mannitol), and 
mixed with 250 mmol/l KOH. Lipids were extracted using chloroform/
methanol (2:1). Samples were dried overnight at room temperature and 
resuspended in buffer B (60% butanol/33% Triton X-114/6.6% metha-
nol). Total triglycerides were quantified using a Triglyceride Assay Kit 
(Sigma) and values were normalized to liver tissue mass.
statistical analysis
Data are expressed as mean ± s.e.m. GraphPad Prism software (version 
5.01; GraphPad Software, La Jolla, CA) was used for statistical analy-
sis. Differences between two groups were determined using unpaired, 
two-tailed Student’s t-test. Where appropriate, data was analyzed by 
 two-way ANOVA to test relative contributions of diet and genotype. 
P ≤ 0.05 was considered significant.
resuLts
cx3cl1 and cx3cr1 expression is increased in epididymal fat 
in mice with hFd-induced obesity
Cx3cl1 and Cx3cr1 gene expression was measured in epididy-
mal (visceral) and inguinal (subcutaneous) adipose depots 
from male C57BL/6J mice fed a ND (4.5% fat) or a HFD (60% 
fat) for 20 weeks to induce obesity. Cx3cl1 and Cx3cr1 expres-
sion was induced in epididymal adipose tissue in obese mice 
but not in inguinal fat, whereas HFD induced Ccl2 and Ccr2 
gene expression in both depots (Figure 1a). Cx3cl1 expres-
sion was induced in adipocytes, but repressed in SVCs during 
HFD-induced obesity (Figure 1b). Consistent with this, Cx3cl1 
expression was induced by lipopolysaccharide in small 3T3-L1 
adipocytes generated by culturing differentiated cells in low 
glucose (5 mmol/l) containing media (Figure 1c). However, 
lipopolysaccharide-induced Cx3cl1 expression was elevated 
more dramatically in large adipocytes grown in high glucose 
(25 mmol/l) concentrations (Figure 1c). In contrast, lipopoly-
saccharide failed to augment Cx3cl1 expression in either bone 
marrow-derived macrophages (BMMφ) or cultured SVCs 
(Figure 1d). These data indicate that adipocytes in visceral fat 
are the primary regulated source of CX3CL1 from obese mice, 
which is consistent with the work of Shah et al. (29). However, 
our data also suggest that hyperglycemia, adipocyte hypertro-
phy, or both may synergize with inflammatory signals to pro-
mote Cx3cl1 expression in adipocytes during HFD-induced 
obesity.
cX3cr1 is expressed on multiple cd11b
+ sVcs in 
epididymal fat from mice
CX3CR1 is expressed on resident type 2 (M2) ATMs in lean 
mice (4), but its distribution in visceral fat during obesity 
has not been characterized. Therefore, we examined the dis-
tribution of CX3CR1-expressing cells in epididymal fat from 
Cx3cr1
+/GFP hemizygous knock-in mice that had been fed a 
HFD for 12–20 weeks. In epididymal fat from obese Cx3cr1
+/GFP, 
the GFP reporter was expressed to varying degrees in F4/80-
expressing ATMs within crown-like structures (Figure 2a). 
GFP expression colocalized with CD11c expression in some, 
but not all, type 1 ATMs in obese mice (Figure 2b). By con-
trast, colocalization of GFP with MGL1+ type 2 ATMs in epidi-
dymal fat was considerably less frequent in obese Cx3cr1
+/GFP 
mice (Figure 2c). Unexpectedly, we detected clusters of GFP-
expressing cells in epididymal fat from both lean (data not 
shown) and obese Cx3cr1
+/GFP mice which did not stain strongly 
for F4/80 (Figure 2d). These GFP+ cells had a unique, dendritic 
cell-like morphology, and these clusters were often found in 
hypervascularized areas devoid of adipocytes (Figure 2d).
To quantify and further phenotype CX3CR1-expressing cells 
in visceral fat, SVCs were isolated from epididymal fat pads of 
lean and obese Cx3cr1
+/GFP mice and examined by flow cytom-
etry. Autofluorescence in SVC preparations and the relative 
infrequency of GFP+ cells in lean Cx3cr1
+/GFP mice prevented 
us from accurately characterizing GFP+ SVCs in fat from lean 
reporter mice by this method (data not shown). However, 
12 weeks of HFD-induced obesity caused a marked increase 
in GFP+ cells in SVC preparations from obese Cx3cr1
+/GFP mice, 
which was distinguishable from background autofluorescence 
(Figure 3a). In obese reporter mice, GFP+ SVCs accounted for 
~20% of all SVCs (21.1 ± 06%; n = 4 mice) (Figure 3a). To 
determine whether GFP+ SVCs were ATMs, SVCs were stained 
for CD11b and F4/80 and divided into CD11bHighF4/80High 
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(herein defined as ATMs) and CD11bHighF4/80Low popula-
tions (Figure 3b). ATMs and CD11bHighF4/80Low SVCs differed 
in Ly-6c expression and light scatter properties (Figure 3c). 
CD11bHighF4/80Low SVCs were Ly-6cHighSSCLowFSCMid suggest-
ing that these cells represent immature myeloid cells (iMCs) 
in fat. iMCs are unlikely to be residual blood monocytes as the 
mice in these experiments were perfused with PBS to remove 
blood before SVC isolation. Notably, GFP+ SVCs made up a 
larger fraction of the iMCs relative to ATMs (28.08 ± 2.98% 
ATMs vs. 49.55 ± 3.39% iMCs; n = 4 mice) (Figure 3d). 
Consistent with our immunofluorescence studies, quantifica-
tion revealed that as many as 8% of all SVCs from epididymal 
fat of obese Cx3cr1
+/GFP mice express GFP, but not F4/80 (8.0 
± 1.76% of total SVCs; n = 4 mice). These cells were SSCLow 
(data not shown), suggesting that they are likely iMCs or an 
altogether distinct leukocyte subset in visceral fat.
GFP+ ATMs and iMCs from epididymal fat were phenotyped 
for markers of type 1 (CD11c) and type 2 (CD206) ATMs to 
determine whether CX3CR1/GFP expression is associated 
with one or both ATM subtypes. Approximately one quarter 
of ATMs from epididymal fat were GFP+CD11c+ (26.7 ± 2.14% 
of ATMs; n = 4 mice) and CD11c expression was comparable 
between GFP+ and GFP− ATMs collected from Cx3cr1
+/GFP mice 
after 12 weeks of HFD (Figure 3f). By contrast, ~15% of GFP+ 
ATMs expressed the type 2 ATM marker CD206 (16.0 ± 2.52% 
of ATMs; n = 4 mice). CD206 expression was markedly higher 
in GFP− ATMs (Figure 3f). This was consistent with our micro-
scopy studies in which we did not observe much colocalization 
of GFP and MGL1 expression in situ (Figure 2c). CD11c was 
also expressed on iMCs from obese reporter mice, and GFP+ 
CD11c+ iMCs made up about 25% of the total iMC popula-
tion (27.9 ± 3.47% of total iMCs; n = 4 mice)(Figure 3g). By 
contrast, iMCs expressed little CD206 (Figure 3g). Taken 
together, our microscopy and flow cytometry studies demon-
strate that CX3CR1 expression is not restricted solely to either 
type 1 or type 2 ATMs in visceral adipose tissue of mice with 
HFD-induced obesity. Rather, we identified CX3CR1 expres-
sion in both type 1 and type 2 ATMs, as well as a population of 
CD11c+F4/80Low iMCs.
Cx3cr1 deficiency in mice does not alter hFd-induced 
monocytosis
Obesity promotes monocytosis (30,31) and CX3CR1 regulates 
blood monocyte homeostasis (23). Therefore, we first investi-
gated the impact of Cx3cr1 deficiency on circulating monocytes 
after short-term (12 weeks) and chronic (40 weeks) exposure 
to HFD. Cx3cr1
GFP/GFP and littermate control (Cx3cr1
+/GFP) mice 
were fed a HFD for various times (12–40 weeks). Cx3cr1
GFP/GFP 
and control mice gained weight at a similar rate and developed 
similar degrees of adiposity in response to HFD-induced obes-
ity (Supplementary Figure S1 online). The number of circulat-
ing CD115+ (Ly-6g−) monocytes in lean Cx3cr1
GFP/GFP mice was 
significantly reduced compared to control mice (Figure 4a), as 
reported (23). Circulating monocytes were elevated in control 
mice after chronic (40 weeks), but not short-term (12 weeks) 




















































































































Epididymal fat Inguinal fat
Figure 1 Cx3cl1 and Cx3cr1 expression is increased in epididymal fat during high-fat diet (HFD)-induced obesity in mice. (a) Chemokine/receptor 
gene expression in epididymal (visceral) and inguinal (subcutaneous) adipose tissue from male C57BL/6J mice fed a normal diet (ND; 4.5% fat; 
n = 4) or HFD (60% fat; n = 4) for 20 weeks. (b) Cx3cl1 expression in isolated adipocytes (Adipo) and stromal vascular cells (SVCs) within epididymal 
fat pads from ND and HFD mice (n = 4 per group). (c) Cx3cl1 expression in differentiated 3T3-L1 adipocytes grown in 5 mmol/l and 25 mmol/l 
glucose and stimulated with lipopolysaccharide (LPS; 100 ng/ml) for 24 h (n = 3–4 replicates per treatment). (d) Cx3cl1 and TNF-α expression in 
bone marrow-derived macrophages (BMMφ) and cultured SVCs stimulated with LPS (100 ng/ml) for 24 h (n = 3 replicates per treatment). *P < 0.05; 
**P < 0.01; ***P < 0.001. TNF-α, tumor necrosis factor-α.
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blunt HFD-induced monocytosis as there were no differences 
in total CD115+ (Ly-6g−) monocytes between obese Cx3cr1
GFP/
GFP and control mice (Figure 4a). Ly-6cLow monocytes were 
reduced in lean Cx3cr1
GFP/GFP mice and after 12 weeks of HFD 
exposure (Figure 4b,c). By contrast, Ly-6cLow monocytes were 
not different in Cx3cr1
GFP/GFP and control mice after 40-weeks of 
HFD (Figure 4c). Relative to control mice, circulating Ly-6cHigh 
monocytes were also reduced in lean Cx3cr1
GFP/GFP mice, but no 
differences in Ly-6cHigh monocytes were seen between genotypes 
after short-term or chronic exposure to HFD (Figure 4d). When 
expressed as the relative change from baseline (% of total blood 
leukocytes in lean mice), Cx3cr1
GFP/GFP mice showed increased 
monocyte mobilization/stability in the circulation with obesity 
compared to controls (Figure 4e). There results demonstrate 
that the initiation and maintenance of monocytosis with obes-
ity is independent of CX3CR1 and implies that HFD-induced 
 obesity activates compensatory mechanisms that overcome 
monocytopenia caused by Cx3cr1 deficiency.
Cx3cr1 deficiency does not alter atM or iMc content, atM 
phenotype, or adipose tissue inflammation in lean or obese 
mice
To evaluate whether CX3CR1 plays a role in the recruitment 
or maintenance of ATMs and/or iMCs in fat, Cx3cr1
GFP/GFP and 
littermate control mice were fed a HFD for different durations 
(0, 12, 16, 30, and 40 weeks), and ATM and iMC content in 
epididymal adipose tissue was examined by flow cytometry. 
Relative to lean mice, the number of SVCs in epididymal fat 
increased 3.5- to fourfold following HFD, but there were no 
differences in the quantity of SVCs in either group of mice at 
any time point (Supplementary Figure S2 online). Total ATM 
content in epididymal fat increased after 12, 16, 30, and 40 
weeks of HFD, but there were no differences between obese 
Cx3cr1
GFP/GFP and control cohorts (Figure 5a). The quantity 
of iMCs decreased in response to HFD; however, we found 
no differences in iMC content between groups (Figure 5b). 
The number of GFP+ ATMs (CD11b+GFP+ and F4/80+GFP+) 
in epididymal adipose tissue was also comparable between 
obese Cx3cr1
GFP/GFP and control mice after 12 weeks of HFD 
(Figure 5c). To rule out the possibility that haploinsufficiency 
of Cx3cr1 in obese control (Cx3cr1
GFP/+) mice may alter ATM/
iMC recruitment, we also compared obese C57BL/6 and 
Cx3cr1
GFP/GFP mice after 20 weeks of HFD but, again, found 
no differences in ATM content in epididymal adipose tissue 
between these two groups (Figure 5d).
We next examined the distribution of type 1 and type 2 ATM 
subtypes in epididymal fat from lean and obese Cx3cr1
GFP/GFP 
and control mice using multiple techniques. By flow cytom-
etry, type 2 (F4/80+ CD11b+CD206+) ATMs were the predomi-
nant ATM subtype in epididymal adipose tissue from both 
lean Cx3cr1
GFP/GFP and control mice, but these populations were 
unaffected by Cx3cr1 deficiency (Figure 6a). Twelve weeks of 
HFD caused an increase in type 1 (F4/80+ CD11b+CD11c+) 
ATMs in both genotypes; however, the relative numbers of 
CD11c+ ATMs did not differ between strains (Figure 6a). 
Furthermore, there were no significant differences in the 
number of CD11c−CD206− or CD11c+CD206+ ATMs between 
groups (Figure 6a). The ratio of type 1:type 2 ATMs increased 
to similar levels in both Cx3cr1
GFP/GFP and control mice after 
12 weeks of HFD, and this was further exaggerated in mice 
with chronic obesity (Figure 6b). Immunofluorescence micro-
scopy demonstrated that Cx3cr1
GFP/GFP and control mice had 
similar numbers of Mac2+ crown-like structures in epididy-
mal fat after 12- and 40-weeks of HFD (Figure 6c and data not 
shown), indicating that the absence of CX3CR1 does not alter 
the formation of crown-like structures with obesity. Finally, 
gene expression analysis performed on whole epididymal adi-
pose tissue from obese Cx3cr1
GFP/GFP and control mice did not 
reveal any significant differences in the expression pattern of 
M1 or M2 macrophage markers, inflammatory cytokines, or 
chemokines between the two strains after 12- or 40-weeks of 
HFD (Figure 6d,e and data not shown).
We also examined the effects of Cx3cr1 deficiency on adipose 
tissue T lymphocytes implicated in adipose tissue inflamma-
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Figure 2 CX3CR1 is expressed on adipose tissue macrophages (ATMs) 
in epididymal adipose tissue. (a) Identification of GFP+ (green) and 
F4/80+ (red) ATMs in epididymal fat from obese Cx3cr1
+/GFP reporter 
mice by confocal microscopy. Isolectin (blue) labels endothelial cells 
and identifies vasculature. (b) GFP+ (green) and CD11c+ (red) type 1 
ATMs in epididymal fat. (c) GFP+ (green) and MGL1+ (red) type 2 ATMs 
in epididymal fat. (d) Representative image of unique GFP+ (green) cell 
clusters in hypervascularized regions devoid of adipocytes and F4/80+ 
(red) ATMs. Caveolin (blue) identifies vasculature. Bar = 100 μm; original 
magnification = ×60. GFP, green fluorescent protein.
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in the number of CD4+ or CD8+ T cells within epididymal adi-
pose tissue when comparing obese Cx3cr1
GFP/GFP and control 
mice (Supplementary Figure S3 online). Collectively, these 
data indicate that CX3CR1 expression is not required for the 
recruitment, turnover, or retention of ATMs or T lymphocytes 
in visceral adipose tissue during HFD.
disruption of cx3cr1 does not impact the development of 
obesity-induced metabolic disease in mice
Since it is plausible that Cx3cr1 deficiency may augment HFD-
induced metabolic disease without affecting obesity-induced 
inflammation in fat, we evaluated glucose metabolism, insulin 
sensitivity, and hepatic triglyceride content in lean and obese 
Cx3cr1
GFP/GFP and control Cx3cr1
GFP/+ mice. Cx3cr1
GFP/GFP and 
control mice developed similar degrees of hyperglycemia and 
hyperinsulinemia during HFD-induced obesity (Figure 7a). 
Glucose and insulin tolerance tests performed after 23 weeks of 
HFD-induced obesity confirmed that, compared to lean con-
trols, obese Cx3cr1
GFP/GFP and control mice had similar impair-
ments in glucose tolerance (Figure 7b) and insulin sensitivity 
(Figure 7c). A independent cohort of Cx3cr1
GFP/GFP mice was 
also indistinguishable from age-matched Cx3cr1
+/+ mice in 
terms of HFD-induced insulin resistance (Supplementary 
Figure S4 online). Cx3cr1
GFP/GFP and Cx3cr1
GFP/+ control mice 
developed similar degrees of liver steatosis in response to HFD 
(Figure 7d,e). This latter finding indicates that CX3CR1 is not 
required for (or protective against) HFD-induced steatosis in 
mice.
dIscussIon
In this study, we examined the hypothesis that the chemokine 
receptor CX3CR1 plays a role in the regulation of monocyte 
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Figure 3 Characterization of CX3CR1/GFP
+ stromal vascular cells (SVCs) in epididymal adipose tissue of obese Cx3cr1
+/GFP mice by flow cytometry. 
Cx3cr1
+/GFP were fed a high-fat diet (HFD; 60% fat) for 12 weeks before SVCs were isolated from epididymal adipose tissue and phenotyped by flow 
cytometry. (a) Identification of GFP+ SVCs in obese Cx3cr1
+/GFP (open) and C57BL/6 (shaded) mice. (b) Identification of CD11bHighF4/80High (adipose 
tissue macrophages; ATMs) and CD11bHighF4/80Low (immature myeloid cells; iMCs) populations in SVCs from obese mice. (c) Representative 
histogram showing Ly-6c expression in ATMs (shaded) and iMCs (open). Scatter plots (SSC vs. FSC) of gated ATMs (middle) and iMCs (right) 
demonstrate the difference in cell size and granularity between the two populations. (d) Distribution of GFP+ SVCs from a representative obese 
Cx3cr1
+/GFP mouse. GFP expression in ATMs and iMCS is shown. (e) Representative scatter plots showing CD11b+GFP− and CD11b+GFP+ SVCs 
(left) and F4/80+GFP− and F4/80+GFP+ SVCs (right) within visceral fat from obese Cx3cr1
+/GFP mice. (f) CD11c+GFP− and CD11c+GFP+ ATMs (left) 
and CD206+GFP− and CD206+GFP+ ATMs (right) within visceral fat from obese Cx3cr1
+/GFP mice. (g) CD11c+GFP− and CD11c+GFP+ iMCs (left) and 
CD206+GFP− and CD206+GFP+ iMCs (right) within visceral fat from from obese Cx3cr1
+/GFP mice. In e–g, percentage of gated cells is indicated in each 
quadrant. APC, allophycocyanin; FSC, forward scatter; GFP, green fluorescent protein; PE, R-phycoerythrin; SSC, side scatter.
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trafficking to adipose tissue during HFD-induced obesity. 
Support for this hypothesis came from the recent observation 
that plasma and adipose tissue levels of fractalkine/CX3CL1, 
the only ligand for CX3CR1, are elevated in obese patients (29). 
We found that hyperglycemia synergizes with inflammatory 
signals to promote Cx3cl1 expression in cultured adipocytes 
and that HFD-induced obesity induces Cx3cr1 expression in 
adipocytes in visceral, but not subcutaneous fat. However, we 
found no significant alterations in ATM accumulation, inflam-




+/GFP reporter mice, we found that CX3CR1 was 
expressed on both type 1 and type 2 ATMs identified by sur-
face marker staining for CD11c and CD206/MGL1, respec-
tively, in both lean and obese mice. However, CX3CR1/GFP 
was not preferentially expressed in either type 1 (CD11c+) or 
type 2 (CD206+/MGL1+) ATMs. Moreover, Cx3cr1 deficiency 
did not the affect the accumulation of GFP+ myeloid cells in 
fat during diet-induced obesity or alter the recruitment of type 
1 ATMs to visceral fat. However, CX3CR1/GFP expression 
did identify a population of cells in situ that morphologically 
resemble CX3CR1
+ dendritic cells in the gut (32). Located in 
hypervascular regions in visceral fat, these cell clusters appear 
to be synonymous with fat-associated lymphoid clusters identi-
fied in mesenteric fat (33). Thus, Cx3cr1
+/GFP reporter mice have 
utility in the identification of fat-associated lymphoid clusters 
in visceral fat in both lean and obese states.
CX3CR1/GFP expression was not confined to ATMs in epidi-
dymal fat. About half of GFP+ CD11b+ SVCs in visceral fat were 
smaller and less granular (FSCmid SSClow) and expressed lower 
levels of F4/80 than ATMs. These cells are similar to F4/80Low 
SVCs previously reported in visceral fat from mice (34,35). Like 
iMCs, F4/80Low SVCs decline progressively with diet-induced 
obesity (35). Notably, F4/80Low SVCs express higher levels of 
Nos2, Ccl5, and Csf1 (macrophage  colony-stimulating fac-
tor) than F4/80High ATMs (35), suggesting that F4/80Low SVCs 
may be a unique reservoir of inflammatory myeloid cells. In 
our study, the surface phenotype of iMCs (Ly-6cHigh, CD11c+, 
CD206−) suggests that these cells may be analogous to classical 
(Ly6cHigh) blood monocytes in the circulation; however, these 
cells were not dissociated from visceral fat by saline perfusion, 
suggesting that iMCs are tissue resident “monocyte-like” cells 
intimately associated with adipocytes or the vasculature within 
the tissue. The expression of CD11c by iMCs raises the pos-
sibility that they may be precursors of CD11c+ inflammatory 
(M1) ATMs. We speculate that obesity accelerates the transi-
tion of iMCs from a “monocyte-like” phenotype to a “macro-
phage-like” state. However, detailed fate mapping studies will 
be required to prove this and to establish the role of these cells 
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Figure 4 Effects of high-fat diet (HFD)-induced obesity on blood monocyte populations in Cx3cr1
GFP/GFP and control mice. Cx3cr1
+/GFP and Cx3cr1
GFP/GFP 
mice were fed a normal diet (ND) or HFD (60% fat) for 12 or 40 weeks before blood leukocytes were examined by flow cytometry. (a) Total circulating 
CD115+ Ly-6g− monocytes in Cx3cr1
+/GFP and Cx3cr1
GFP/GFP mice. (b) Representative scatter plots showing the distribution of blood monocyte subsets 
(Ly-6cHigh and Ly-6cLow) from lean (ND) and obese (12- and 40-weeks HFD) mice. (c,d) Quantification of blood monocyte subsets after gating Ly-6cHigh 
and Ly-6cLow populations as indicated in b. (e) Relative change in blood monocytes in Cx3cr1
+/GFP and Cx3cr1
GFP/GFP mice with HFD-induced obesity. 
Data are expressed as percentage of total blood leukocytes from lean mice. n = 5–8 per group; *P < 0.05; ***P < 0.001; †P < 0.05 vs. ND. GFP, green 
fluorescent protein.
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Atherosclerosis and obesity-induced adipose tissue inflam-
mation are very similar inflammatory diseases, with many of 
the same inflammatory mediators (e.g., monocytes, macro-
phages, dendritic cells, T cells, B cells, etc.) (11,12). Currently, it 
is largely assumed that leukocyte trafficking to atherosclerotic 
plaques and trafficking of leukocytes to obese adipose tissue 
is regulated by a similar set of chemokine signals (e.g., CCL2/
CCR2 and CX3CL1/CX3CR1). Why then does disruption of 
the CX3CL1-CX3CR1 pathway attenuate foam cell formation 
in atherosclerotic vessels, but does not impact ATM accumula-
tion in mouse models of diet-induced obesity? Several differ-
ences potentially exist in mice models of these two diseases 
that may explain why CX3CR1 is required for one process but 
not the other.
Monocytosis is a hallmark of murine models of atherosclero-
sis and diet-induced obesity. Classical (Ly-6cHigh) and nonclas-
sical (Ly-6cLow) blood monocytes are elevated in Apoe−/− mice 
(14,27). CX3CR1 is required for the trafficking of Ly-6c
High 
monocytes to atherosclerotic lesions (14,22) and the CX3CL1-
CX3CR1 pathway also promotes survival of Ly-6c
Low monocytes 
(23). Thus, Cx3cr1−/−Apoe−/− mice are protected from atherogen-
esis due to a combination of defective monocyte trafficking and 
impaired monocyte survival. By contrast, classical (Ly-6cHigh) 
blood monocytes as well as CD11c+ monocytes are elevated in 
mouse models of obesity (31). The importance of Ly-6cHigh blood 
monocytes in the progression of HFD-induced inflammation in 
fat and metabolic disease is underscored by studies showing that 
type 1 ATM accumulation, inflammation, and metabolic disease 
are all attenuated in obese Ccr2−/− and Mgl1−/− mice that have few 
circulating Ly-6cHigh monocytes (4–5,15). In our experiments, 
both Ly-6cHigh and Ly-6cLow blood monocytes increased with 
HFD-induced obesity, but these increases were not dependent 
on CX3CR1. Ly-6c
Low blood monocytes were reduced after 12 
weeks of HFD in Cx3cr1
GFP/GFP mice, suggesting that CX3CR1 
is required for their survival in diet-induced obesity. However, 
reduced Ly-6cLow monocytes did not alter ATM accumulation 
in epididymal fat from obese Cx3cr1
GFP/GFP mice, suggesting that 
nonclassical monocytes likely contribute little to the obesity-in-
duced accumulation of type 1 ATMs in visceral fat. These find-
ings highlight the need for a more sophisticated understanding 
a










































































































 deficiency does not alter adipose tissue macrophage (ATM) content in visceral fat from lean or obese mice. Cx3cr1
+/GFP and Cx3cr1
GFP/
GFP mice were fed a normal diet (ND) or high-fat diet (HFD) for 12, 16, 30 or 40 weeks before stromal vascular cells (SVCs) were isolated from 
epididymal adipose tissue and examined by flow cytometry. (a) ATM content in epididymal fat shown as percentage of total SVCs and normalized to 
visceral fat mass. (b) Immature myeloid cell (iMC) content in epididymal fat shown as percentage of total SVCs and normalized to visceral fat mass. 
(c) Distribution of GFP+ and GFP− SVCs in visceral fat after 12 weeks of HFD. Data are shown as percentage of total SVCs. (d) ATM content in 
visceral fat from C57BL/6 and Cx3cr1
GFP/GFP mice after 20 weeks of HFD. Data are shown as percentage of total SVCs and normalized to visceral fat 
mass. ND: n = 4 per group; HFD: n = 4–5 per group; †P < 0.05 vs. ND. GFP, green fluorescent protein.
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of the mechanisms that guide and sustain monocyte egress from 
bone marrow and splenic reservoirs during diet-induced obesity 
in mice models.
The development of atherosclerosis and adipose tissue 
inflammation with obesity have been shown to be dependent 
upon the CCR2 (13–16). Like our current study, others have 
reported that chemokines known to be involved in athero-
genesis (e.g., CCL2, MIP-1α/CCL3) are induced in obese vis-
ceral fat (36,37). However, genetic disruption of many of these 
chemokines does not attenuate the accumulation of inflamma-
tory ATMs in HFD-fed mice (36,37). This suggests that there 
is considerable redundancy in chemotaxic signals that drive 
monocyte trafficking to fat. Alternatively, chemokine-inde-
pendent signals (e.g., lipolysis, ref. (38)) may play an important 
role in mediating ATM recruitment to visceral fat, at least in 
mice models. Clearly, additional work is needed to clarify the 
importance of chemokine-dependent and -independent sig-
nals in the regulation of leukocyte trafficking to fat.
Monocyte extravasation into damaged tissues requires che-
moattraction, rolling adhesion, arrest/tight adhesion, and 
endothelial transmigration. The CX3CL1/CX3CR1 interac-
tion is critical for monocyte extravasation in atherosclerotic 
vessels due in part to the ability of fractalkine/CX3CL1 to 
act as an adhesion molecule (14,22). At present, very little is 
known about how monocyte extravasation occurs in lean and 
obese fat. The frequency of slow rolling leukocytes in adipose 
tissue vasculature increases during obesity, and intercellular 
adhesion molecule-dependent arrest/adhesion of leukocytes 
has been documented in blood vessels within adipose tissue 
from obese mice (39). However, it is not known which other 
adhesion molecules are required or sufficient to promote 
leukocyte entry into fat. Our results suggest that CX3CL1/
CX3CR1 pathway is dispensable for monocyte extravasation 
into fat. Thus, the function of CX3CL1–CX3CR1 interactions 
























































































































































 deficiency does not alter the distribution of type 1 and type 2 adipose tissue macrophages (ATMs) in epididymal adipose tissue 
from lean or obese mice. Cx3cr1
+/GFP and Cx3cr1
GFP/GFP mice were fed a normal diet (ND) or high-fat diet (HFD) for 12 weeks before stromal vascular 
cells (SVCs) were isolated from epididymal fat and examined by flow cytometry. (a) Distribution of ATM subsets in visceral fat from Cx3cr1
+/GFP and 
Cx3cr1
GFP/GFP mice shown as percentage of total ATMs. (b) Ratio of type 1 (CD11c+) to type 2 (CD206+) ATMs in visceral fat after 12- and 40-weeks 
of HFD. (c) ATM infiltration assessed by immunofluorescence microscopy. Caveolin (green) and Mac2 (red) staining in epididymal fat from obese 
(12 weeks HFD) mice. Bar = 100 μm. (d) Relative expression of M1 and M2 macrophage markers in visceral fat from Cx3cr1
+/GFP and Cx3cr1
GFP/GFP 
mice after 12 weeks of HFD. (e) Relative expression of a subset of cytokines and chemokines in epididymal fat after 12 weeks of HFD. n = 4–5 mice 
per group. †P < 0.05 vs. ND. CLS, crown-like structures; GFP, green fluorescent protein.
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Atherosclerosis and obesity are similar in that they are lipid 
storage diseases, but there are notable differences between 
mouse models of atherosclerosis (e.g., Apoe−/− mice) and mice 
with HFD-induced obesity. For one, Apoe−/− mice remain more 
insulin sensitive than wild-type mice when both are fed mod-
est 20% fat diets (40). By contrast, recombinant adiponectin 
attenuates inflammation and improves insulin sensitivity 
in mice with HFD-induced obesity, but is unable to modify 
atherosclerosis progression in Apoe−/− mice (41). These find-
ings, coupled to the our findings that CX3CR1 is not required 
for ATM recruitment, highlight a critical point of divergence 
between the mechanisms that regulate foam cell formation in 
atherosclerosis and ATM accumulation with obesity. Thus, 
the idea that the factors that regulate foam cell formation dur-
ing atherogenesis are synonymous with those that promote 
ATM accumulation in obesity needs to be revisited to provide 
opportunities for new mechanisms of monocyte trafficking to 
be discovered.
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